Concentrix (NASDAQ:CNXC - Get Free Report) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.570-2.690 for the period, compared to the consensus earnings per share estimate of 2.670. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 11.480-12.070 EPS.
Concentrix Trading Up 1.4%
Concentrix stock traded up $0.38 during midday trading on Thursday, reaching $28.11. 500,105 shares of the stock traded hands, compared to its average volume of 1,505,561. The company has a 50-day simple moving average of $32.10 and a two-hundred day simple moving average of $38.33. Concentrix has a 12-month low of $24.27 and a 12-month high of $62.14. The firm has a market cap of $1.73 billion, a PE ratio of -1.30, a price-to-earnings-growth ratio of 0.34 and a beta of 0.50. The company has a current ratio of 1.18, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43.
Concentrix (NASDAQ:CNXC - Get Free Report) last announced its earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing analysts' consensus estimates of $2.65 by ($0.04). Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. The firm had revenue of $2.50 billion for the quarter, compared to analysts' expectations of $2.49 billion. During the same quarter last year, the business earned $2.79 earnings per share. The business's revenue was up 5.4% compared to the same quarter last year. Research analysts expect that Concentrix will post 10.11 earnings per share for the current fiscal year.
Concentrix Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Stockholders of record on Friday, April 24th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Friday, April 24th. Concentrix's dividend payout ratio (DPR) is presently -6.68%.
Analysts Set New Price Targets
Several brokerages have recently weighed in on CNXC. Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a "buy" rating on the stock in a research report on Wednesday, March 25th. Wall Street Zen lowered Concentrix from a "buy" rating to a "hold" rating in a research report on Saturday, March 28th. Robert W. Baird cut their target price on Concentrix from $52.00 to $40.00 and set an "outperform" rating on the stock in a research report on Wednesday, March 25th. Weiss Ratings lowered Concentrix from a "hold (c-)" rating to a "sell (d)" rating in a research report on Thursday, January 29th. Finally, Barrington Research cut their target price on Concentrix from $62.00 to $38.00 and set an "outperform" rating on the stock in a research report on Wednesday, March 25th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $48.50.
Read Our Latest Stock Report on Concentrix
Insider Buying and Selling
In other news, CEO Christopher A. Caldwell bought 1,000 shares of the firm's stock in a transaction on Thursday, January 29th. The shares were bought at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.90% of the company's stock.
Institutional Trading of Concentrix
Institutional investors have recently bought and sold shares of the company. Geneos Wealth Management Inc. boosted its position in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after purchasing an additional 522 shares in the last quarter. Larson Financial Group LLC raised its holdings in shares of Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company's stock worth $32,000 after acquiring an additional 479 shares during the last quarter. Global Retirement Partners LLC raised its holdings in shares of Concentrix by 1,032.5% in the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company's stock worth $36,000 after acquiring an additional 795 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Concentrix in the third quarter worth $69,000. Finally, Osaic Holdings Inc. raised its holdings in shares of Concentrix by 13.4% in the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company's stock worth $118,000 after acquiring an additional 263 shares during the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.
About Concentrix
(
Get Free Report)
Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.